Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004017376 | SCV004849272 | uncertain significance | Cardiovascular phenotype | 2017-04-07 | criteria provided, single submitter | clinical testing | The c.1100G>T (p.R367L) alteration is located in exon 9 (coding exon 8) of the SCN5A gene. This alteration results from a G to T substitution at nucleotide position 1100, causing the arginine (R) at amino acid position 367 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Cardiovascular Biomedical Research Unit, |
RCV000058391 | SCV000089911 | not provided | Brugada syndrome | no assertion provided | literature only | This variant has been reported as associated with Brugada syndrome in the following publications (PMID:20129283). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. |